Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $8.6 million.

  • Arcadia Biosciences' Liabilities and Shareholders Equity fell 4367.82% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.9 million, marking a year-over-year decrease of 3727.56%. This contributed to the annual value of $13.5 million for FY2024, which is 3140.32% down from last year.
  • Arcadia Biosciences' Liabilities and Shareholders Equity amounted to $8.6 million in Q3 2025, which was down 4367.82% from $7.8 million recorded in Q2 2025.
  • Arcadia Biosciences' 5-year Liabilities and Shareholders Equity high stood at $70.8 million for Q1 2021, and its period low was $7.8 million during Q2 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $26.8 million (2023), whereas its average is $30.2 million.
  • Per our database at Business Quant, Arcadia Biosciences' Liabilities and Shareholders Equity surged by 11954.85% in 2021 and then plummeted by 5516.15% in 2025.
  • Quarter analysis of 5 years shows Arcadia Biosciences' Liabilities and Shareholders Equity stood at $43.9 million in 2021, then crashed by 34.15% to $28.9 million in 2022, then plummeted by 31.87% to $19.7 million in 2023, then tumbled by 31.4% to $13.5 million in 2024, then crashed by 36.49% to $8.6 million in 2025.
  • Its last three reported values are $8.6 million in Q3 2025, $7.8 million for Q2 2025, and $13.0 million during Q1 2025.